Old West Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-281
Closed -$45K 49
2021
Q4
$45K Sell
281
-1,129
-80% -$248K 0.02% 47
2021
Q3
$384K Hold
1,410
0.1% 45
2021
Q2
$558K Buy
1,410
+23
+2% +$10.7K 0.12% 48
2021
Q1
$748K Hold
1,387
0.16% 45
2020
Q4
$524K Sell
1,387
-15
-1% -$5.96K 0.12% 44
2020
Q3
$529K Sell
1,402
-2
-0.1% -$884 0.12% 42
2020
Q2
$690K Sell
1,404
-1
-0.1% -$446 0.2% 36
2020
Q1
$516K Sell
1,405
-28
-2% -$14.5K 0.39% 39
2019
Q4
$1.01M Hold
1,433
0.37% 41
2019
Q3
$920K Sell
1,433
-54
-4% -$42.8K 0.54% 43
2019
Q2
$1.3M Sell
1,487
-2
-0.1% -$1.38K 0.61% 41
2019
Q1
$859K Hold
1,489
0.31% 50
2018
Q4
$417K Buy
1,489
+1,321
+786% +$522K 0.11% 60
2018
Q3
$80K Hold
168
0.03% 76
2018
Q2
$76K Buy
168
+22
+15% +$13.9K 0.04% 72
2018
Q1
$85K Sell
146
-14
-9% -$8.72K 0.05% 77
2017
Q4
$99K Sell
160
-21
-12% -$15.1K 0.06% 69
2017
Q3
$166K Sell
181
-15
-8% -$13.3K 0.09% 65
2017
Q2
$182K Sell
196
-20
-9% -$19.6K 0.1% 65
2017
Q1
$205K Buy
+216
New +$201K 0.11% 59

Other funds holding TCRT

Old West Investment Management's TCRT Position: Q1 2022 in Review

Old West Investment Management sold out of Alaunos Therapeutics (TCRT) in Q1 2022, closing a stake of 281 shares — an estimated $45K sold.

Old West Investment Management first reported a position in TCRT in Q1 2017 and held it in 20 quarters. The position peaked at $1.3M in Q2 2019. 148 funds tracked by Wall St. Rank hold TCRT as of Q1 2022.

  • Old West Investment Management reported no remaining Alaunos Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Old West Investment Management sold 281 Alaunos Therapeutics shares in Q1 2022, an estimated $45K.
  • Old West Investment Management first reported a position in Alaunos Therapeutics in Q1 2017 and held it in 20 quarters.
  • Old West Investment Management's Alaunos Therapeutics position peaked at $1.3M in Q2 2019.
  • 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2022.

Based on Old West Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.